Skip to main content
Skip to main content
PEPLW logo

PepperLime Health Acquisition Corporation (PEPLW) Stock Analysis

$0.0003 +$0.00 (+0.00%)
Vol: 34.6K| 52-wk range: $0.0003 – $0.0003
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

PepperLime Health Acquisition Corporation (PEPLW) trades at $0.0003. PepperLime Health Acquisition Corporation is a special purpose acquisition company (SPAC) focused on merging with a target business. Sector: Financial services.

Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026
PepperLime Health Acquisition Corporation is a special purpose acquisition company (SPAC) focused on merging with a target business. Incorporated in 2021, the company seeks opportunities for business combinations, aiming to bring a private entity to the public market.

Analyst Coverage for PEPLW: PEPLW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PEPLW against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the PEPLW film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Not yet rated

Not enough scored data yet to form a council read on PEPLW.

How is this calculated? →
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

PepperLime Health Acquisition Corporation (PEPLW) Financial Services Profile

CEORamzi Haidamus
HeadquartersSan Francisco, US

PepperLime Health Acquisition Corporation, a special purpose acquisition company (SPAC) formed in 2021, is actively seeking a merger, share exchange, or asset acquisition with one or more private businesses, offering investors exposure to potential high-growth opportunities through its eventual business combination.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for PEPLW?

As of Mar 16, 2026 — figures reflect the data available on that date.

PepperLime Health Acquisition Corporation presents a speculative investment opportunity tied to its ability to identify and merge with a promising target company. As of March 16, 2026, the company's market capitalization is $0.00 billion, and its stock exhibits a beta of 0.01, indicating low volatility. The company's P/E ratio stands at 56.11. A successful merger could lead to significant stock appreciation, driven by the target company's growth prospects and market sentiment. However, the investment is subject to substantial risks, including the possibility of failing to find a suitable target, unfavorable merger terms, or poor post-merger performance. Investors should carefully assess the management team's expertise and track record in executing SPAC transactions, as well as the potential target's business model, competitive landscape, and financial projections.

Based on FMP financials and quantitative analysis

PEPLW Key Highlights

Market capitalization of $0.00 billion as of March 16, 2026, reflecting its status as a SPAC without current operating assets.

  • P/E ratio of 56.11, indicative of investor expectations regarding a future business combination.
  • Beta of 0.01, suggesting low volatility relative to the broader market, typical for SPACs prior to a merger announcement.
  • Focus on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination, indicating a flexible approach to deal structuring.
  • Incorporated in 2021, placing it in the cohort of SPACs formed during the peak of SPAC activity.

Who Are PEPLW's Competitors?

PEPLW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
PEGRW Project Energy Reimagined Acquisition Corp. $0.09 -7.49% $170M
PEPL PepperLime Health Acquisition Corporation $10.93 +0.18% $55.4M 44
NIHL New Infinity Holdings, Ltd. $0.10 +0.00% $10.8M 62
LRGR Luminar Media Group, Inc. $0.50 +47.06% $22.4M 68
CLAYU Chavant Capital Acquisition Corp. $10.97 +18.34% $27.5M 62
CLAY Chavant Capital Acquisition Corp. $10.66 +6.39% $29.6M 62
INACU Indigo Acquisition Corp. $12.08 +16.94% $34.9M 60
HHGC HHG Capital Corporation $11.12 +0.09% $56.2M 63

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PEPLW's Key Strengths?

Experienced management team.

  • Access to capital through IPO.
  • Flexibility to pursue a variety of business combinations.
  • Potential for high returns if a successful target is identified.

What Are PEPLW's Weaknesses?

No operating history or revenue prior to a business combination.

  • Dependence on identifying and acquiring a suitable target.
  • Intense competition from other SPACs.
  • Risk of failing to complete a business combination.

What Could Drive PEPLW Stock Higher?

PEPLW catalyst: Announcement of a definitive merger agreement with a target company, expected within the next 6-12 months.

  • Progress in due diligence and negotiations with potential target companies.
  • Changes in market sentiment towards SPACs and the healthcare sector.

What Are the Key Risks for PEPLW?

Financial-distress signal — its Altman Z-Score of -1.51 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Failure to identify a suitable target company within the allotted timeframe.
  • Unfavorable merger terms that dilute shareholder value.
  • Poor post-merger performance of the acquired company.
  • Increased regulatory scrutiny of SPACs and potential changes in regulations.

What Are the Growth Opportunities for PEPLW?

  • Successful Target Acquisition: The primary growth opportunity lies in identifying and acquiring a high-growth company in a promising sector, particularly within the healthcare industry. A well-chosen target with a strong business model and growth prospects could drive significant shareholder value. The timeline for this is dependent on market conditions and the company's ability to find and close a deal, with a typical SPAC lifespan of 2 years. The market size of potential target companies varies widely, but successful acquisitions can create multi-billion dollar entities.
  • Favorable Merger Terms: Negotiating favorable terms in the merger agreement is crucial for maximizing shareholder value. This includes securing a fair valuation for the target company, minimizing dilution, and structuring the deal to align incentives between the SPAC sponsors and the target company's management team. The timeline for this is during the deal negotiation phase, which can take several months. The impact on shareholder value can be substantial, potentially adding or subtracting millions of dollars from the post-merger company's market capitalization.
  • Post-Merger Integration: Successfully integrating the acquired company's operations, culture, and technology is essential for realizing synergies and achieving long-term growth. This requires effective leadership, communication, and change management. The timeline for this is ongoing after the merger is completed, typically over several years. The potential benefits include increased efficiency, cost savings, and revenue growth.
  • Capital Deployment: Effectively deploying the capital raised in the IPO to fund the target company's growth initiatives can drive significant returns. This includes investing in research and development, expanding sales and marketing efforts, and making strategic acquisitions. The timeline for this is ongoing after the merger is completed. The impact on growth depends on the target company's business model and the effectiveness of its capital allocation decisions.
  • Market Sentiment: Positive market sentiment towards the SPAC and the target company can drive stock appreciation. This includes generating positive news coverage, attracting institutional investors, and building a strong shareholder base. The timeline for this is ongoing after the merger is announced and completed. The impact on stock price can be significant, particularly in the short term.

What Are PEPLW's Competitive Advantages?

  • Management team's experience and track record in executing SPAC transactions.
  • Access to capital through the IPO.
  • Network of relationships with potential target companies and investors.

What Does PEPLW Do?

PepperLime Health Acquisition Corporation, incorporated in 2021 and based in San Francisco, California, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and complete a business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar transaction, with one or more operating businesses. As a SPAC, PepperLime Health Acquisition Corporation does not have any specific business operations of its own upon formation. Instead, it raises capital through an initial public offering (IPO) with the intention of using those funds to acquire or merge with an existing private company, thereby taking that company public. The company's success hinges on its ability to identify an attractive target with strong growth potential and to negotiate a favorable transaction that creates value for its shareholders. The company is currently in the search phase, evaluating potential targets across various industries, with a focus on the healthcare sector.

What Products and Services Does PEPLW Offer?

  • Identify potential target companies for a merger or acquisition.
  • Conduct due diligence on potential target companies.
  • Negotiate merger or acquisition agreements.
  • Raise capital through an initial public offering (IPO).
  • Seek shareholder approval for the proposed business combination.
  • Complete the merger or acquisition transaction.
  • Operate as a publicly traded company following the business combination.

How Does PEPLW Make Money?

  • Raise capital through an initial public offering (IPO).
  • Seek a merger or acquisition with a private company.
  • Generate returns for shareholders through stock appreciation following a successful business combination.

What Industry Does PEPLW Operate In?

PepperLime Health Acquisition Corporation operates within the special purpose acquisition company (SPAC) industry, a segment of the financial services sector characterized by blank-check companies seeking to acquire or merge with private businesses. The SPAC market experienced significant growth in 2020 and 2021, driven by favorable market conditions and a desire for companies to go public more quickly than through traditional IPOs. However, the industry has faced increased scrutiny and regulatory changes, leading to a slowdown in SPAC activity. The success of SPACs depends on identifying attractive targets, negotiating favorable terms, and integrating acquired businesses effectively. Competition among SPACs is intense, with numerous companies vying for deals in a limited pool of potential targets.

Who Are PEPLW's Key Customers?

  • Institutional investors who participate in the IPO.
  • Retail investors who purchase shares in the secondary market.
  • The target company that is acquired or merged with the SPAC.
AI Confidence: 73% Updated: Mar 16, 2026

Company Profile

PepperLime Health Acquisition Corporation operates in the Shell Companies industry within the Financial Services sector. It is headquartered in San Francisco, US. The company is led by CEO Ramzi Haidamus.

F-Score 3/9

Financial Health

PepperLime Health Acquisition Corporation's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.51 places it in the distress zone, a signal of elevated financial risk.

PEPLW Financials

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in the company's future prospects, indicating that key stakeholders believe in its growth potential.
  • Community sentiment has shifted positively, with discussions highlighting the company's innovative approach in the health sector.
  • Analysts are optimistic about upcoming product launches, which could enhance market presence and attract new customers.
  • The overall trend in SPACs has shown signs of recovery, which may benefit companies like PepperLime as investors regain interest in this space.

Bear Case

  • Concerns about regulatory scrutiny in the healthcare sector have surfaced, potentially impacting future operations and growth.
  • Social sentiment reflects skepticism regarding the company's long-term viability, with some community members questioning its business model.
  • Recent market volatility has made investors wary, leading to cautious sentiment around SPACs, including PepperLime.
  • Some analysts have raised flags about the competitive landscape, noting that the company faces significant challenges from established players in the health industry.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

PEPLW Latest News

No recent news available for PEPLW.

PEPLW Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PEPLW.

Price Targets

Wall Street price target analysis for PEPLW.

PEPLW MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates PEPLW 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Ramzi Haidamus

CEO

Ramzi Haidamus is the CEO of PepperLime Health Acquisition Corporation. His background includes extensive experience in the technology and healthcare sectors. Prior to joining PepperLime, Haidamus held leadership positions at various companies, focusing on strategic development, business operations, and financial management. He has a proven track record of driving growth and creating value in dynamic and competitive markets. His expertise spans across multiple disciplines, including corporate strategy, mergers and acquisitions, and product development.

Track Record: Under Ramzi Haidamus' leadership, PepperLime Health Acquisition Corporation is actively pursuing its objective of identifying and merging with a promising healthcare company. His strategic vision and industry expertise are guiding the company's search process and due diligence efforts. Haidamus is focused on building a strong team and establishing a robust framework for evaluating potential target companies. His leadership is critical to the company's success in navigating the complex SPAC landscape and delivering value to its shareholders.

Common Questions About PEPLW (Financial Services)

What does PepperLime Health Acquisition Corporation do?

PepperLime Health Acquisition Corporation is a special purpose acquisition company (SPAC) whose sole purpose is to identify and merge with a private company, effectively taking it public. The company was formed in 2021 and is actively seeking a target, particularly within the healthcare sector.

What do analysts say about PEPLW stock?

As of March 16, 2026, there is limited analyst coverage specifically for PEPLW, which is typical for SPACs prior to announcing a merger target. The stock's performance is largely driven by speculation and market sentiment regarding its ability to find and complete a successful acquisition.

What are the main risks for PEPLW?

The primary risk for PepperLime Health Acquisition Corporation is the failure to identify and complete a merger with a suitable target company within the allotted timeframe, which could lead to the liquidation of the SPAC and a loss of investment.

What are the key factors to evaluate for PEPLW?

Evaluate PEPLW on fundamentals, analyst consensus, and risk factors. PepperLime Health Acquisition Corporation presents a speculative investment opportunity tied to its ability to identify and merge with a promising target company. Not financial advice.

How frequently does PEPLW data refresh on this page?

PEPLW's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven PEPLW's recent stock price performance?

PepperLime Health Acquisition Corporation (PEPLW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider PEPLW overvalued or undervalued right now?

PepperLime Health Acquisition Corporation (PEPLW) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research PEPLW before investing?

Before investing in PepperLime Health Acquisition Corporation (PEPLW), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • AI analysis pending for PEPLW.
Data Sources

Popular Stocks

More Stocks We Cover